Skip to main content
Home
 
 
 
MENU
Home
Janssen’s COVID-19 Vaccine Status >

Janssen Global Main Menu

  • Our Company
    • About Us
    • Contact Us
    • Grants & Giving
    • News Center
    • Our Leaders
    • Patient Safety information
    • Products
    • Sustainability
    • Transparency
    • VISIT JANSSEN IN YOUR COUNTRY
  • Our Focus
    • Therapeutic Areas
    • Cardiovascular, Metabolism and Retina
    • Immunology
    • Infectious Diseases & Vaccines
    • Neuroscience
    • Oncology
    • Pulmonary Hypertension
    • Patient Engagement
  • Our Science
    • Our Response to COVID-19
    • Clinical Trials
    • Compassionate Use & Pre-Approval Access
    • R&D Data Science
    • Janssen Global Trial Finder
    • World Without Disease Accelerator
    • Janssen Clinical Innovation
    • Precision Medicine & Janssen Diagnostics

Our Stories List

Making a Splash for Disease Awareness
Global_Trial_Finder
Making a Splash for Disease Awareness
Looking Under the Hood for Green Chemistry Solutions
Global_Trial_Finder
Looking Under the Hood for Green Chemistry Solutions
  • Return to home

Global Trial Finder

  • text size

My Saved Trials

Nipocalimab in Moderate to Severe Sjogren's Disease (DAFFODIL)

Last Updated   May 14, 2025

Want to learn how to participate in this trial?

80202135SJS3001

OVERVIEW

  • Sexes Eligible for Study
    all
  • Age
    18+ years
  • Phase
    phase 3
  • Sites
    56 Sites
  • Status
    Recruiting

SUMMARY

This clinical development program for nipocalimab in SjD includes 2 identical double blind, placebo-controlled studies to evaluate the efficacy, safety, and tolerability of nipocalimab in participants greater than or equal to (>=) 18 years of age with moderate to severe SjD.

CONDITIONS

  • Sjogrens Syndrome

ELIGIBILITY


Inclusion Criteria:

* Medically stable on the basis of physical examination, medical history, vital signs, clinical laboratory tests, and 12-lead electrocardiogram (ECG) performed at screening
* Meets criteria for diagnosis of SjD by the 2016 American College of Rheumatology/European Alliance of Associations for Rheumatology (ACR/EULAR) classification criteria
* Seropositive for antibodies to Ro/SSA (Ro60 and/or Ro52) at screening
* Total ClinESSDAI score greater than or equal to (>=) 5 at screening
* Participants of childbearing potential must have a negative highly sensitive serum (beta-hCG) pregnancy test at screening and a negative urine pregnancy test at Week 0 prior to randomization


Exclusion Criteria:

* Has a history of severe, progressive and/or uncontrolled hepatic, gastrointestinal, renal, pulmonary, cardiovascular, psychiatric, neurological or musculoskeletal disorder, hypertension, and/or any other medical or uncontrolled autoimmune disorder or clinically significant abnormalities in screening laboratory
* Known allergies, hypersensitivity, or intolerance to nipocalimab or its excipients or excipients used in the placebo formulation
* Has any confirmed or suspected clinical immunodeficiency syndrome not related to treatment of his/her SjD or has a family history of congenital or hereditary immunodeficiency
* Has shown a previous severe immediate hypersensitivity reaction, such as anaphylaxis, to therapeutic proteins (for example [e.g.], monoclonal antibodies, intravenous immunoglobulin)
* Has any unstable or progressive manifestation of SjD that is likely to warrant escalation in therapy beyond permitted background medications


Inclusion Criteria:

* Medically stable on the basis of physical examination, medical history, vital signs, clinical laboratory tests, and 12-lead electrocardiogram (ECG) performed at screening
* Meets criteria for diagnosis of SjD by the 2016 American College of Rheumatology/Euro

More...

DETAILS

LOCATIONS

Locations in:
United States, Japan, Taiwan, United Kingdom, Argentina, Brazil, South Korea, Mexico
Country (8) City or Province (56) Status
United States Upland Inland Rheumatology Clinical Trials Inc.
RECRUITING
United States Skokie Clinical Investigation Specialists - Clinic of Robert Hozman
RECRUITING
United States Duncansville Altoona Center For Clinical Research
RECRUITING
United States Denver Denver Arthritis Clinic
RECRUITING
United States New Port Richey Suncoast Clinical Research
RECRUITING
United States South Miami BioResearch Partner
RECRUITING
United States Eagan St. Paul Rheumatology P A
RECRUITING
United States Salisbury Onsite Clinical Solutions
RECRUITING
United States Jackson West Tennessee Research Institute
RECRUITING
Japan Chuo ku St. Luke's International Hospital
RECRUITING
Japan Fukuoka National Hospital Organization Kyushu Medical Center
RECRUITING
Japan Kawachi Nagano National Hospital Organization Osaka Minami Medical Center
RECRUITING
Japan Naha Shinkenko Clinic
RECRUITING
Japan Sasebo Sasebo Chuo Hospital
RECRUITING
Japan Sendai Tohoku Medical And Pharmaceutical University Hospital
RECRUITING
Japan Sumida ku Tokyo Metropolitan Bokutoh Hospital
RECRUITING
Taiwan Kaohsiung City Kaohsiung Chang Gung Memorial Hospital
RECRUITING
Taiwan Taipei Taipei Veterans General Hospital
RECRUITING
Taiwan Taoyuan Linkou Chang Gung Memorial Hospital
RECRUITING
United Kingdom Swindon Great Western Hospital
RECRUITING
United States Fullerton Providence Medical Foundation
RECRUITING
United States Clearwater Clinical Research of West Florida Inc
RECRUITING
United States Sarasota Sarasota Arthritis Center
RECRUITING
United States Charlotte Atrium Health SouthPark Rheumatology
RECRUITING
United States Fairborn Wright State Physicians Health Center
RECRUITING
United States Bellevue Overlake Arthritis and Osteoporosis Center
RECRUITING
Argentina Buenos Aires Instituto Medico De Alta Complejidad (IMAC)
RECRUITING
Argentina Ciudad de Buenos Aires Centro de Investigacion en Enfermedades Reumaticas CIER
RECRUITING
Argentina Ciudad de Buenos Aires Centro Medico Barrio Parque. Swiss Medical Group
RECRUITING
Argentina Ciudad de Buenos Aires Cosultorios Reumatologógicos Pampa
RECRUITING
Argentina San Miguel De Tucuman Centro de Investigaciones Medicas Tucuman
RECRUITING
Brazil Curitiba Ceti - Centro de Estudos Em Terapias Inovadoras
RECRUITING
Brazil Sao Jose do Rio Preto Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto Hospital de Base
RECRUITING
Brazil Sao Paulo EBSERH Empresa de Servicos Hospitalares Hospital Samaritano
RECRUITING
Brazil Sao Paulo CEPIC Centro Paulista de Investigacao Clinica e Servicos Medicos
RECRUITING
Brazil Vitoria CEDOES Centro de Pesquisa Clinica e Diagnostico do Espirito Santo Ltda
RECRUITING
Japan Fuchu Tokyo Metropolitan Tama Medical Center
RECRUITING
Japan Okayama Okayama City General Medical Center Okayama City Hospital
RECRUITING
Japan Sapporo Hokkaido University Hospital
RECRUITING
Japan Shimotsuga Gun Dokkyo Medical University Hospital
RECRUITING
Japan Tokyo Nihon University Itabashi Hospital
RECRUITING
South Korea Gwangju Chonnam National University Hospital
RECRUITING
South Korea Seoul Hanyang University Medical Center
RECRUITING
South Korea Seoul Konkuk University Medical Center
RECRUITING
South Korea Seoul The Catholic University of Korea Seoul St Mary s Hospital
RECRUITING
South Korea Suwon si Ajou University Hospital
RECRUITING
Mexico Culiacan Centro de Investigacion de Tratamientos Innovadores de Sinaloa
RECRUITING
Mexico Guadalajara Clinica de Investigacion en Reumatologia y Obesidad
RECRUITING
Mexico Merida Medical Care & Research SA de CV
RECRUITING
Mexico Mexico CITER Centro de Investigacion y Tratamiento de las Enfermedades Reumaticas S A de C V
RECRUITING
Mexico Queretaro SMIQ S de R L de C V
RECRUITING
Taiwan Hsinchu City NTU Biomedical Park Hospital
RECRUITING
United Kingdom Doncaster Doncaster Royal Infirmary
RECRUITING
United Kingdom Greater London Barts Health NHS Trust
RECRUITING
United Kingdom Liverpool University Hospital Aintree
RECRUITING
United Kingdom Peterborough Peterborough City Hospital
RECRUITING
Show More
Geo Locations

34.09751, -117.64839

42.03336, -87.73339

40.42341, -78.4339

39.73915, -104.9847

28.24418, -82.71927

25.7076, -80.29338

44.80413, -93.16689

35.67097, -80.47423

35.61452, -88.81395

35.57779, 139.71685

33.6, 130.41667

34.44108, 135.58283

26.21667, 127.68333

33.16832, 129.72501

38.26667, 140.86667

35.6948198, 139.8185403

22.61626, 120.31333

25.04776, 121.53185

24.95233, 121.20193

51.55797, -1.78116

33.87029, -117.92534

27.96585, -82.8001

27.33643, -82.53065

35.22709, -80.84313

39.82089, -84.01938

47.61038, -122.20068

-34.61315, -58.37723

-34.61315, -58.37723

-34.61315, -58.37723

-34.61315, -58.37723

-26.82414, -65.2226

-25.42778, -49.27306

-20.81972, -49.37944

-23.5475, -46.63611

-23.5475, -46.63611

-20.31944, -40.33778

35.6916009, 139.4620918

34.65, 133.93333

43.06667, 141.35

36.4729244, 139.8232641

35.6895, 139.69171

35.15472, 126.91556

37.566, 126.9784

37.566, 126.9784

37.566, 126.9784

37.29111, 127.00889

24.79032, -107.38782

20.66682, -103.39182

20.97537, -89.61696

19.42847, -99.12766

20.5734792, -100.382075

24.8138287, 120.9674798

53.52285, -1.13116

51.5250491, -0.0421792

53.41058, -2.97794

52.57364, -0.24777

x
50

Indicates 50+ sites in this region: click to zoom in.

10

Indicates 10+ sites in this region: click to zoom in.

5

Indicates < 10 sites in this region: click to zoom in.

Corresponds to individual site.

Interested in participating?

×

Confirm


If you are interested in this clinical trial, we will use your email address to respond to your questions and fulfill your requests as necessary for our legitimate interest and possibly to comply with our legal obligations relating to pharmacovigilance. Please read our Privacy Policy.

Footer

  • PRIVACY POLICY
  • LEGAL NOTICE
  • COOKIE POLICY
  • COOKIE SETTINGS
  • CAREERS
  • NEWS CENTER
  • DO NOT SELL MY PERSONAL INFORMATION

Footer Social

Find Janssen Global on:

twitter youtube linkedin

Janssen Global Policy text

©Johnson & Johnson Innovative Medicine. All Rights Reserved. This website is hosted and operated by Johnson & Johnson Innovative Medicine, which is solely responsible for its content. This website is intended for a global audience.